Burt Wealth Advisors’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-445
Closed 391
2020
Q4
$0 Hold
445
﹤0.01% 429
2020
Q3
$1K Hold
445
﹤0.01% 390
2020
Q2
$2K Hold
445
﹤0.01% 358
2020
Q1
$2K Hold
445
﹤0.01% 360
2019
Q4
$1K Buy
+445
New +$1.16K ﹤0.01% 334

Other funds holding BMY.RT

Burt Wealth Advisors's BMY.RT Position: Q1 2021 in Review

Burt Wealth Advisors sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 445 shares.

Burt Wealth Advisors first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $2K in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Burt Wealth Advisors reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Burt Wealth Advisors sold 445 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021.
  • Burt Wealth Advisors first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Burt Wealth Advisors's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $2K in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Burt Wealth Advisors's 13F filing for Q1 2021, filed 15 Apr 2021.